Recruiting NA Chronic Low Back Pain

New treatment option for Chronic Low Back Pain

Official title MBM and taVNS for Low Back Pain and Depressive Symptoms

ClinicalTrials.gov ID: NCT07415941

What this study is testing

What it's testing
This two-arm randomized controlled trial aims to test the preliminary effect of home-based mindfulness-based meditation and transcutaneous auricular vagus nerve stimulation on managing pain and depressive symptoms among community-dwelling older adults with chronic low back pain and depressive symptoms; and the effect of home-based mindfulness-based meditation and transcutaneous auricular vagus nerve stimulation on the host Brain-Gut Axis.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 to 85

You may be able to join if

  • aged 50 to 85 years old
  • intact cognition (examined by the Mini-Mental State Exam, ≥ 24)
  • experiencing moderate low back pain daily or almost every day at least the previous three months (≥3 out of 10 on numeric rating scale [NRS])
  • experiencing elevated depressive symptoms with the patient health questionnaire (PHQ-9) total score ranging between 5 to 19
  • able to speak and read English

You likely can't join if

  • serious underlying illness (e.g., malignant neoplasms),
  • other psychosis,
  • elevated suicide risk as indicated by the Columbia-Suicide Severity Rating Scale (C-SSRS) score \> 2,
  • function limitation precluded the meditation practice,
  • participated meditation program before,
  • any other conditions/contraindications that prohibit the application of taVNS including but not limited to any current or past history of...
See the full eligibility criteria
Who can join
  • aged 50 to 85 years old
  • intact cognition (examined by the Mini-Mental State Exam, ≥ 24)
  • experiencing moderate low back pain daily or almost every day at least the previous three months (≥3 out of 10 on numeric rating scale [NRS])
  • experiencing elevated depressive symptoms with the patient health questionnaire (PHQ-9) total score ranging between 5 to 19
  • able to speak and read English
  • not intent to change medication regimens for pain throughout the trial.
What rules you out
  • serious underlying illness (e.g., malignant neoplasms),
  • other psychosis,
  • elevated suicide risk as indicated by the Columbia-Suicide Severity Rating Scale (C-SSRS) score \> 2,
  • function limitation precluded the meditation practice,
  • participated meditation program before,
  • any other conditions/contraindications that prohibit the application of taVNS including but not limited to any current or past history of cardiovascular disorders, recent ear trauma, and metal implants above the level...
  • no access to the internet.

The study team makes the final eligibility decision.

Where it's taking place

  • Tallahassee, Florida, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years to 85 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Tallahassee, Florida, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.